Evidence map›Paper›PMID 30063648›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2018

Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans.

Alex Olson, Elizabeth J Ragan, Lydia Nakiyingi, Nina Lin, Karen R Jacobson, Jerrold J Ellner, Yukari C Manabe, Manish Sagar

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. iScience · 2023
    Article
  7. PET/CT imaging of CSF1R in a mouse model of tuberculosis.European journal of nuclear medicine and molecular imaging · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Alex OlsonDivision of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA.
Elizabeth J RaganDivision of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA.
Lydia NakiyingiInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Nina LinDivision of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA.
Karen R JacobsonDivision of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA.
Jerrold J EllnerDivision of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA.
Yukari C ManabeInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Manish SagarDivision of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA.
Boston University · USJohns Hopkins University · USMakerere University · UG

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Persistent HIV expression induced type I IFN responses and inflammagingR01AG060890 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM, LIN, NINA H. · 2018 to 2022
$3.8M
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.D43TW009771 · FIC · JOHNS HOPKINS UNIVERSITY · PI CASTELNUOVO, BARBARA, KAMBUGU, ANDREW DDUNGU · 2014 to 2023
$3.3M
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital TractR01AI122209 · NIAID · BOSTON MEDICAL CENTER · PI SAGAR, MANISH · 2015 to 2019
$2.2M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUKL2TR000102 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2014
$1.7M
FIC NIH HHS D43 TW009771NCATS NIH HHS KL2 TR000102NCATS NIH HHS UL1 TR001430NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI122209NIA NIH HHS R01 AG060890
6 · The paper itself

Abstract

backgroundMycobacterium tuberculosis (TB) infection induces systemic inflammation that could impact HIV-1 persistence.

settingHIV-1-seropositive individuals either with or without pulmonary TB disease were recruited in Kampala, Uganda.

methodsPlasma cytokines, HIV-1 DNA, and cell-associated (ca)-RNA were compared among those coinfected with TB (cases) to those without TB (controls). TB-coinfected cases and controls were compared at presentation (n = 15 and n = 16, respectively) and at around 6 months after HIV-1 treatment initiation among those who had achieved virologic suppression (n = 6 and n = 8, respectively). At follow-up, the TB-coinfected cases had also finished TB treatment.

resultsBefore treatment, the TB-coinfected cases as compared to the controls had higher levels of soluble(s)-CD163 (P = 0.0002) and interleukin-6 (P = 0.006) but lower levels of macrophage chemoattractant protein-1 (P = 0.04). After treatment, the TB-coinfected cases as compared to controls still had higher plasma s-CD163 levels (P = 0007). Controls as compared to the coinfected cases had higher ca-RNA per DNA template both at baseline (P = 0.03) and at follow-up (P = 0.07). Levels of ca-RNA per DNA copy at follow-up showed a negative correlation with baseline plasma s-CD163 (P = 0.008) and interleukin-6 (P = 0.05) levels.

conclusionsTB disease is associated with inflammation and decreased HIV-1 RNA expression relative to the number of infected cells, both before and after viral suppression. Infections present before antiretroviral initiation impact HIV-1 latency.

Indexed as

Viral LoadVirus LatencyAdultAnti-HIV AgentsAntitubercular AgentsCoinfectionCytokinesDNA, ViralFemaleFollow-Up StudiesHIV-1HIV InfectionsHumansInflammationMaleMiddle AgedAnti-HIV AgentsAntitubercular AgentsCytokinesDNA, ViralRNA, Viral

Identifiers

PMID30063648
PMCPMC6506856
OpenAlexW2885141539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.